Properties of Therapeutic Mucilage – Effect of Mucilage Syrup

Marshmallow root syrup (*Althaea officinalis*) is derived through a carefully controlled extraction process applied to the plant’s subterranean rhizomes, which are harvested during the autumnal vegetative dormancy period—typically in the second or third growing season. The raw material undergoes gentle drying at temperatures not exceeding 40°C to preserve the bioactivity of its high-molecular-weight mucilaginous polysaccharides. These compounds exhibit a unique capacity to form a protective colloidal layer over mucosal surfaces, making the syrup a valuable adjunctive therapy for respiratory conditions (including bronchitis and pharyngeal irritation) as well as for alleviating symptoms of gastroesophageal reflux, hyperacidity of gastric juice, and inflammatory disorders of the gastric and duodenal mucosa. A single therapeutic dose of the syrup corresponds to the equivalent of 5 grams of dried marshmallow root, ensuring an optimal concentration of active principles [1–3].

The syrup derived from the root extract of marshmallow (*Althaea officinalis*) is employed to alleviate irritation and inflammatory conditions affecting the mucosal lining of the upper respiratory tract, particularly when accompanied by a persistent, non-productive cough. Its efficacy stems from the presence of high-molecular-weight mucilaginous polysaccharides, which form a protective hydrophilic layer over the epithelial surface. This mechanism not only provides immediate relief from pharyngeal and laryngeal discomfort but also ensures prolonged hydration and mitigation of mechanical or chemical irritants. According to the Summary of Product Characteristics and patient information leaflets, the preparation may be effectively utilized as an adjunctive therapy for conditions such as acute and chronic pharyngitis, laryngitis, acute and chronic bronchitis, as well as hoarseness, esophageal irritation, and dry cough of varied etiology—including that associated with viral upper respiratory tract infections [2–4]. Certain sources additionally suggest its potential benefits in alleviating symptoms of streptococcal tonsillitis (as supportive treatment) and tracheal inflammation [5].

An examination of available sources, including the package inserts of marshmallow root-based preparations, reveals significant restrictions on the use of this remedy by pregnant women, primarily due to the insufficient number of controlled clinical trials conducted in this specific patient group and the presence of ethanol as an excipient. Similar constraints apply to the pediatric population—because of the potential risks associated with alcohol exposure, the preparation is not recommended for children under the age of 6. The standard dosage for adults and adolescents over 12 years of age is 15 milliliters three times daily, whereas for children aged 6 to 12 years—unless individualized medical recommendations are provided—a dose of 5 milliliters, also three times daily, is indicated [2, 3].

It is noteworthy that marshmallow root syrup demonstrates efficacy in managing both non-productive and productive coughs. This versatility stems from the presence of specialized mucilaginous polysaccharides in the plant’s root, which serve a dual purpose: firstly, they form a protective, moisture-retaining layer over mucosal surfaces, thereby soothing irritation—an effect particularly beneficial for dry coughs; secondly, they modulate the viscosity and volume of bronchial secretions, facilitating expectoration in cases of wet cough and thereby enhancing the patient’s respiratory comfort [2, 3].

Phytochemical analysis of marshmallow (*Althaea officinalis*), a member of the mallow family (*Malvaceae*), has revealed a complex array of bioactive compounds whose presence was first documented as early as the mid-20th century. Among the primary constituents are high-molecular-weight polysaccharides with mucilaginous properties, alongside starch, pectins, and a diverse range of secondary metabolites, including flavonoid glycosides, phenolic acid derivatives (such as caffeic and ferulic acids), and coumarins. Systematic investigation into these components has laid the foundation for contemporary research into the plant’s therapeutic potential, encompassing both its traditional applications and emerging clinical study pathways.

The pharmacotherapeutic benefits associated with marshmallow root (*Althaea officinalis*) are primarily attributable to its rich composition of specialized secondary metabolites, which demonstrate a marked capacity to scavenge reactive oxygen species. Notable among these are polyphenolic compounds—including flavonones and flavonoid glycosides—as well as hydroxycinnamic acid derivatives and coumarins, whose mechanisms of action involve the modulation of inflammatory pathways through the suppression of pro-inflammatory mediators such as cytokines and eicosanoids. Furthermore, this botanical source synthesizes substantial quantities of mucilaginous polysaccharides (predominantly glucans and arabinogalactans), which form colloidal solutions exhibiting protective properties for the epithelial linings of the respiratory and gastrointestinal tracts. These polysaccharides exert a soothing effect on irritated tissues while facilitating the repair of damaged mucosal barriers. Additionally, the carbohydrate fractions contribute to the organoleptic profile of the raw material, rendering it a desirable functional ingredient in food technology, particularly in nutrient-dense formulations.

Among the vast array of medicinal plants employed in herbal medicine, the root of marshmallow (*Althaea officinalis*) occupies a distinguished position alongside its aerial parts—leaves and flowers—as a therapeutically valuable raw material. The overwhelming majority of scientific investigations into its medicinal properties have focused specifically on the root, which contains the highest concentration of bioactive mucilaginous polysaccharides. Clinical and experimental studies have substantiated that marshmallow root extract demonstrates significant efficacy in soothing irritation of the respiratory mucosa, suppressing inflammatory cough reflexes, and promoting gingival tissue regeneration in periodontal disease. Furthermore, its immunomodulatory effects have been documented, particularly in enhancing phagocytic activity of macrophages—a mechanism that may contribute to reduced duration of viral infections. Certain reports also suggest a potential postprandial hypoglycemic effect, though the underlying pathways require further elucidation. In clinical practice, marshmallow root is most commonly utilized in standardized liquid or dry extracts incorporated into cough syrups, lozenges, and oral rinses. However, despite promising *in vitro* and *in vivo* findings, phytotherapy—even when based on well-studied botanicals such as marshmallow—should be regarded as a complementary rather than substitutive approach to conventional medical treatment. Any decision to integrate herbal remedies, particularly in chronic conditions or cases requiring pharmacological intervention, must be preceded by consultation with a physician or certified herbalist. Within the spectrum of medicinal plants, marshmallow stands out for its versatile therapeutic profile, rendering it a valuable adjunct in the supportive management of respiratory disorders (including cough associated with common colds), pharyngeal inflammation, and mild oral mucosal irritations.